Variability in quality of life outcomes following a pulmonary rehabilitation program in patients with COPD

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 38, Issue 2, 2018, Pages 118-123

  Porto, Elias F ^a,b   Castro, Antonio A M ^a,b,c   Cortopassi, Felipe ^a,d   de Souza, Gerson F ^a   Jardim, José R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Adventist University   (Brazil)

^c UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

COPD; Exercise training; Health related quality of life; Pulmonary rehabilitation; St George Respiratory Questionnaire

Indexed keywords

AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; ENDURANCE TRAINING; EXERCISE TEST; FEMALE; HUMAN; INCREMENTAL EXERCISE TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; EXERCISE TOLERANCE; KINESIOTHERAPY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 85047806926     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0000000000000292     Document Type: Article

References (32)

1. Spruit MA, Pitta F, Garvey C, et al. Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J. 2014;43(5):1326-1337.
2. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-e64.
3. Stewart DG, Drake DF, Robertson C, Marwitz JH, Kreutzer JS, Cifu DX. Benefits of an inpatient pulmonary rehabilitation program: a prospective analysis. Arch Phy Med Rehabil. 2001;82(3):347-352.
4. Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD—its impact on health service utilisation and quality of life, a community study. Age Ageing. 2006;35(1):33-37.
5. Martin A, Rodriguez-Gonzalez Moro JM, Izquierdo JL, Gobartt E, de Lucas P. Health-related quality of life in outpatients with COPD in daily practice: the VICE Spanish Study. Int J Chron Obstruct Pulmon Dis. 2008;3(4):683-692.
6. 1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? Eur Respir J. 2005;25(4):587-588.
7. Fuchs-Climent D, Le Gallais D, Varray A, Desplan J, Cadopi M, Prefaut CG. Factor analysis of quality of life, dyspnea, and physiologic variables in patients with chronic obstructive pulmonary disease before and after rehabilitation. Am J Phys Med Rehabil. 2001;80(2):113-120.
8. Ketelaars CA, Schlosser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, Wouters EF. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax. 1996;51(1):39-43.
9. Mahler DA, Faryniarz K, Tomlinson D, et al. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest. 1992;102(2): 395-401.
10. Guell R, Casan P, Belda J, et al. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest. 2000;117(4): 976-983.
11. Clini EM, Crisafulli E, Costi S, et al. Effects of early inpatient rehabilitation after acute exacerbation of COPD. Respir Med. 2009; 103(10):1526-1531.
12. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Resp Crit Care Med. 1995;152(3):1107-1136.
13. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis. 1969;99(5): 696-702.
14. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014; 44(6):1428-1446.
15. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respi J. 2002;19(3): 398-404.
16. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361-370.
17. Kabat H. Studies on neuromuscular dysfunction. XV. The role of central facilitation in restoration of motor function in paralysis. Arch Phys Med. 1952;33(9):521-533.
18. Jones PW. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. Eur Respir J. 1994;7(1):55-62.
19. Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol Respir Environ Exerc Physiol. 1983; 55(5):1558-1564.
20. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-381.
21. Rochester CL, Vogiatzis I, Holland AE, et al. An Official American Thoracic Society/European Respiratory Society Policy Statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015;192(11):1373-1386.
22. Spruit MA, Augustin IM, Vanfleteren LE, et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J. 2015;46(6):1625-1635.
23. Scott AS, Baltzan MA, Fox J, Wolkove N. Success in pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Can Respir J. 2010;17(5):219-223.
24. de Torres JP, Pinto-Plata V, Ingenito E, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121(4): 1092-1098.
25. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J. 2006;27(4): 788-794.
26. Breslin E, van der Schans C, Breukink S, et al. Perception of fatigue and quality of life in patients with COPD. Chest. 1998;114(4): 958-964.
27. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6): 1245-1257.
28. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498-1504.
29. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmaco-therapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332-338.
30. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728-735.
31. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155(4):1278-1282.
32. Yuan W, He X, Xu QF, Wang HY, Casaburi R. Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients. BMC Pulm Med. 2014;14:16.